Log In
Print
BCIQ
Print
Print this Print this
 

HDC docetaxel (STA-9183)

  Manage Alerts
Collapse Summary General Information
Company Synta Pharmaceuticals Corp.
DescriptionHsp90-inhibitor drug conjugate (HDC) composed of an inhibitor of heat shock protein 90 (Hsp90) joined to docetaxel via a cleavable chemical linker
Molecular Target Heat shock protein 90 (Hsp90)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat solid tumors
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today